Haemonetics: Fiscal Third Quarter Earnings Overview

Haemonetics Reports Strong Third-Quarter Results

Haemonetics Corp., headquartered in Boston, announced on Thursday that it achieved a net profit of $44.7 million for its fiscal third quarter.

The company reported earnings of $0.95 per share. When excluding amortization and one-time expenses, adjusted earnings reached $1.31 per share.

These figures surpassed analyst expectations, as six experts polled by Zacks Investment Research had predicted earnings of $1.27 per share.

Haemonetics, known for its blood management solutions for healthcare organizations and blood collection agencies, generated $339 million in revenue during the quarter. This result also exceeded forecasts, with four Zacks analysts anticipating $334.2 million.

Looking ahead, the company projects its full-year earnings to fall between $4.90 and $5.00 per share.

This article was produced by Automated Insights using information from Zacks Investment Research.